Dual drug targets advanced breast cancerProgression-free survival increased significantly with T-DM1 treatment Sunitinib feasible after brain metastases surgeryPilot investigation suggests drug may offer alternative to radiation therapy Kidney cancer patients prefer pazopanib over sunitinib Newer agent comes out tops in blinded crossover trial Selumetinib shows promise in ovarian cancer Oral MEK inhibitor produces ‘striking’ results in early clinical trial Hypoxia predicts prostate cancer recurrence Low tumour oxygenation linked with biochemical relapse within 48 months of treatment Metformin slows prostate cancer growth Small Canadian study measures markers of cell proliferation Trials fine-tune treatment of low-risk thyroid cancer Less radioiodine as effective as higher dose, studies show Scan kids with caution Beware circulating cells New study backs flexible sigmoidoscopy as screening tool Major U.S. trial shows reduction in colorectal cancer mortality First Previous 45 46 47 48 49 Next Last
